COVRE ALESSIA | Elenco docenti

Di Giacomo, A.M., Chiarion-Sileni, V., Del Vecchio, M., Ferrucci, P.F., Guida, M., Quaglino, P., et al. (2024). Nivolumab plus ipilimumab in melanoma patients with asymptomatic brain metastases: 7-year outcomes and quality of life from the multicenter phase III NIBIT-M2 trial. EUROPEAN JOURNAL OF CANCER, 199 [10.1016/j.ejca.2024.113531]. - dettaglio
Noviello, T.M.R., Di Giacomo, A.M., Caruso, F.P., Covre, A., Mortarini, R., Scala, G., et al. (2023). Guadecitabine plus ipilimumab in unresectable melanoma: five-year follow-up and integrated multi-omic analysis in the phase 1b NIBIT-M4 trial. NATURE COMMUNICATIONS, 14(1) [10.1038/s41467-023-40994-4]. - dettaglio
Montico, B., Giurato, G., Pecoraro, G., Salvati, A., Covre, A., Colizzi, F., et al. (2022). The pleiotropic roles of circular and long noncoding RNAs in cutaneous melanoma. MOLECULAR ONCOLOGY, 16(3), 565-593 [10.1002/1878-0261.13034]. - dettaglio
Anichini, A., Molla, A., Nicolini, G., Perotti, V.E., Sgambelluri, F., Covre, A., et al. (2022). Landscape of immune-related signatures induced by targeting of different epigenetic regulators in melanoma: implications for immunotherapy. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 41(1), 1-15 [10.1186/s13046-022-02529-5]. - dettaglio
Sabato, C., Noviello, T.M.R., Covre, A., Coral, S., Caruso, F.P., Besharat, Z.M., et al. (2022). A novel microRNA signature for the detection of melanoma by liquid biopsy. JOURNAL OF TRANSLATIONAL MEDICINE, 20(1), 1-14 [10.1186/s12967-022-03668-1]. - dettaglio

Tutte le pubblicazioni